{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"dock8-immunodeficiency","columns":[{"gene":"","key":"population-200c4488f51e17d84e10","label":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","mondoId":"MONDO:0009478","onsetQualifier":null,"originColumnKey":"MONDO:0009478/OMIM:243700","originalViews":[{"key":"MONDO:0009478/OMIM:243700","label":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","scopeLabel":"OMIM:243700","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["09da94b197819f48b5786a3dc265e04d6d266c1f4afbc064f23a894e4d71c659","1634202d1f495ac9fb9f0b358d64e087bad907234e3b7870099f04ab10100bca","2696b017d1ba380e8d03781a2b6973e6fcc8313dca9b1b9824f2115380cabcfb","2c4f0b7039e0b30f861dbbc6fa8228bf053b9bd2eb9ad8a643df47ae0fce77fc","30b93fb8c88eb93e3f2dde80f83c689ab5d05f0e4098b07f8530b279a46ec178","36821bffc8369872fac45920f2ad4723524f69c4c7efb7754e5d38e66e2041d1","3696fafd31050f41af74f6916dc90a9cf14a162033a28fbc87005edb1bb55da7","37dda3dd76fae1c333e3301d76d2bfec91dd3fc988566a76fbd845d0bf586856","42e00840f8b6d66673be0313cea395c5f7211a7c1762928e14a147335956ee10","4332fcbea139fd6a06f7cf58dbd17f16160cfabee8c20004a630250ebfd6137f","56c888373c351108153d95e32623be0ac0e546d8b2b00f2d017be2d323870e1d","699dc8f2a13edd96c4e6e1cf984fdf5b390ad2af0a90ece9d8b8a73df6e920c7","69d9236437b48941e56266dd637210a0447aa00fd2945a3e887adee2d6501bce","69da6303530c697c2e94f4f9cf05ce7a5ae64241a2514358cc98760a5cd587e1","79808c2bd97821990b2c9d40dfffffa49e54d9155e637c75ea4dc3c32797a783","7a77ee770930598201cef257599b5a8ffe103b20ad81707faa32496d1b7f47df","903bbf9d6a98cbe9ff27bbd3607356ee36d1b7c00ccc1a897ed77a942b602614","934b4160b133d084c9ef1fa4fba1f35dad82bccf020b152affd74610cdd0c337","95778c2d844198aaf6bb1e0327acbb0f6f188508c82d4d7d72e8d2c6ebdd79f6","98fe339075583b5f97da91af2c6f6f780d71269dbf64d37191200a986e234dca","9d2bb86cb39ce2e8ea0bc23742063869dfdc56e8ce9f08bac513da8566677410","a602497c9eaa5f494cd15a872d2a7fdc29d285014b90dbfd7160827141432e2e","a7a0422b2ed28595bcf10948489fed630a1e6ad5b98253a09b7a2c7c9984fba8","b48aef7f4069081fb925b7d0f7d9c500cd87b2d07250a9a482063f92605fb793","bd175346e36b6f812c07ce6749197cbee534cb380c7f5170e77b6835a9f9fd66","c4c66fdbe6939fe54e66528c0f348f49e2863c9a0d3cdeb912d28edf2ff1ff6c","c52b388dba1f0ed61c07aa470e033cb07eebdd0d205642fba3d586333363aa3a","ca117ee9c1fd1cf8ee306010e7491e632f4edfcf12e1d385fa18ba825a483da5","cb3cf3b7dde5fd52f57d4f1d96232a90b1e918b2f682b14a0e6ec2d7eabc3728","cfff3f75e3427431f084835fa29c624e9440e54aa7bb1e63d8b9fa8ac9ed2b87","e020ceee54deffeb732d135d2d6622720dafac4d9181ef1378edf1b83a1c6ae1","e770b57b0f29f8331873221ac47ccd1901ca8c8c623589c7b155925beafa9737","f03c376119f129e1d184ddf5badd0e8b62d7a8d95877fc2c7b279dadbc2a9862","f08c894210f20e2ea9eb371b8fc6d3d684bccb5b9bd97b9e86e2cbd6fc8a5062","f671d4cfefa31ce13e09fa7536a9a6266f0a9b6e18d8b3737af99059c81db849","f91174eb4664c2adf2a0fcc5bb78508e75229dbb684d33377baf3fb6f9d91f22","fa6c8b36c0cd6cdfe3f4878398e42b78ad0e0b62be6b89e35ea13088f9496793","fdcb0f8f462513bd74080518d599b1bc4670b05b46d4f194776cf8bdd396f13e"],"recordQualifiers":{},"scopeLabel":"OMIM:243700","sourceIds":["OMIM:243700"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-52ab1e7d846eb19ecfdd","label":"Combined immunodeficiency due to DOCK8 deficiency","mondoId":"MONDO:0009478","onsetQualifier":null,"originColumnKey":"MONDO:0009478/ORPHA:217390","originalViews":[{"key":"MONDO:0009478/ORPHA:217390","label":"Combined immunodeficiency due to DOCK8 deficiency","scopeLabel":"ORPHA:217390","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["00d4710d1d3fe210e251917d302c0a1075b04b1e1300eb32cb233a35ec19b127","0395f054842b369b0365e8a7f8596d3b757ee828fdc868a329dd4c4e81dc2d84","20893992683e1fe0a7898a967ff45590c91e027231bb16459906271f86b0eb82","213a345a1ac39c6d7ef0b20c7438654ca2ee656a84771a17a0cdc2e613f768e0","272192a07a80cf363a3581a358f2d671604e44b40fa2b1d5c65b25a6b4a405bd","31dfdf8049c5037651e1f313cd97a9c3c9c5c35dcb65fd1991c4c755fafc38e9","3c55d570cc083708cbda7d22878323c94ff8a5f164c27e6bf0d571ab658723f5","585b983b20821cca03635cc8dcaf950760fd5c2992163ac0d2269a084beb8fc6","8cfa8eb31f536c8b0f09db395ac7fa6e37d29b7c9be0061d42694fa2745ec948","9358bf55d246846b7e4038f0ff4c58b92d61bf9beda18f887f4f962f2e7f7dfc","970298651c7022157e3da45b8a01bc559ae32ca4bac8971a9112501360c2f171","b855b185005b09aa461e754e294b944d620a92391ba1d0dcac30fc97c4a4676c","c21f783da58aeb0b727af42b1e2c5f35d2b39b0738ea699aa7ea823042598318","c2a348605b4a4fb89f3a6ae858bb9f38a0cf3f5e0d9f300fc007a5b31430a3d7","ddfd5c42814749d45b8d1e3a29ff5b72ed69dd78cb848006377ef13b3b970ea0","f64ddcf6fcebec7a75d6eebb12da55f42800c1d16e9a56685b88b95bfca6244b","f68484c90465cd432f0c07db198ea58b00ef8b42eaed0554fcadafeffa7aae45","fa658b5bd3e781b61b0f18f45e2db046dabb73a8535ac1e78e87cdc17579c902"],"recordQualifiers":{},"scopeLabel":"ORPHA:217390","sourceIds":["ORPHA:217390"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-200c4488f51e17d84e10","population-52ab1e7d846eb19ecfdd"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003193","HP:0006763","HP:0100845","HP:0002099","HP:0001047","HP:0002960","HP:0002110"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":33,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":56,"sourceGroups":{"omim":5,"orphanet":18,"published":33}},"features":[{"hpoId":"HP:0003193","label":"Allergic rhinitis","primary":true},{"hpoId":"HP:0006763","label":"Anal canal squamous carcinoma","primary":true},{"hpoId":"HP:0100845","label":"Anaphylactic shock","primary":true},{"hpoId":"HP:0002099","label":"Asthma","primary":true},{"hpoId":"HP:0001047","label":"Atopic dermatitis","primary":true},{"hpoId":"HP:0002960","label":"Autoimmunity","primary":true},{"hpoId":"HP:0002110","label":"Bronchiectasis","primary":true},{"hpoId":"HP:0005318","label":"Cerebral vasculitis","primary":false},{"hpoId":"HP:0000389","label":"Chronic otitis media","primary":false},{"hpoId":"HP:0031292","label":"Cutaneous abscess","primary":false},{"hpoId":"HP:0002850","label":"Decreased circulating IgM concentration","primary":false},{"hpoId":"HP:0010976","label":"Decreased total B cell count","primary":false},{"hpoId":"HP:0032218","label":"Decreased total CD4+ T cell proportion","primary":false},{"hpoId":"HP:0005403","label":"Decreased total T cell count","primary":false},{"hpoId":"HP:0032185","label":"Disseminated molluscum contagiosum","primary":false},{"hpoId":"HP:0410323","label":"Drug allergy","primary":false},{"hpoId":"HP:0000964","label":"Eczematoid dermatitis","primary":false},{"hpoId":"HP:0410151","label":"Eosinophilic infiltration of the esophagus","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0500093","label":"Food allergy","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0002301","label":"Hemiplegia","primary":false},{"hpoId":"HP:0003212","label":"Increased circulating IgE concentration","primary":false},{"hpoId":"HP:0003237","label":"Increased circulating IgG concentration","primary":false},{"hpoId":"HP:0001880","label":"Increased total eosinophil count","primary":false},{"hpoId":"HP:0002754","label":"Osteomyelitis","primary":false},{"hpoId":"HP:0002090","label":"Pneumonia","primary":false},{"hpoId":"HP:0025419","label":"Pulmonary pneumatocele","primary":false},{"hpoId":"HP:0002718","label":"Recurrent bacterial infections","primary":false},{"hpoId":"HP:0005406","label":"Recurrent bacterial skin infections","primary":false},{"hpoId":"HP:0005401","label":"Recurrent Candida infection","primary":false},{"hpoId":"HP:0002841","label":"Recurrent fungal infections","primary":false},{"hpoId":"HP:0000403","label":"Recurrent otitis media","primary":false},{"hpoId":"HP:0006532","label":"Recurrent pneumonia","primary":false},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":false},{"hpoId":"HP:0005425","label":"Recurrent sinopulmonary infections","primary":false},{"hpoId":"HP:0011108","label":"Recurrent sinusitis","primary":false},{"hpoId":"HP:0004429","label":"Recurrent viral infections","primary":false},{"hpoId":"HP:0040218","label":"Reduced total natural killer cell count","primary":false},{"hpoId":"HP:0030991","label":"Sclerosing cholangitis","primary":false},{"hpoId":"HP:0100806","label":"Sepsis","primary":false},{"hpoId":"HP:0031691","label":"Severe viral infection","primary":false},{"hpoId":"HP:0200042","label":"Skin ulcer","primary":false},{"hpoId":"HP:0002860","label":"Squamous cell carcinoma","primary":false},{"hpoId":"HP:0030417","label":"Squamous cell carcinoma of the vulva","primary":false},{"hpoId":"HP:0002138","label":"Subarachnoid hemorrhage","primary":false},{"hpoId":"HP:0012203","label":"Unusual fungal nail infection","primary":false},{"hpoId":"HP:0032163","label":"Unusual molluscum contagiosum","primary":false},{"hpoId":"HP:0200043","label":"Verrucae","primary":false}],"ledeHtml":"DOCK8 immunodeficiency syndrome is a disorder of the immune system. The condition is characterized by recurrent infections that are severe and can be life-threatening. The infections can be caused by bacteria, viruses, or fungi. Skin infections cause rashes, blisters, accumulations of pus (abscesses), open sores, and scaling. People with DOCK8 immunodeficiency syndrome also tend to have frequent bouts of pneumonia and other respiratory tract infections. Other immune system-related problems in people with DOCK8 immunodeficiency syndrome include an inflammatory skin disorder called eczema, food or environmental allergies, and asthma. DOCK8 immunodeficiency syndrome is characterized by abnormally high levels of an immune system protein called immunoglobulin E (IgE) in the blood; the levels can be more than 10 times higher than normal for no known reason. IgE normally triggers an immune response against foreign invaders in the body, particularly parasitic worms, and plays a role in allergies. It is unclear why people with DOCK8 immunodeficiency syndrome have such high levels of this protein. People with DOCK8 immunodeficiency syndrome also have highly elevated numbers of certain white blood cells called eosinophils (hypereosinophilia). Eosinophils aid in the immune response and are involved in allergic reactions. Some people with DOCK8 immunodeficiency syndrome have neurological problems, such as paralysis that affects the face or one side of the body (hemiplegia). Blockage of blood flow in the brain or abnormal bleeding in the brain, both of which can lead to stroke, can also occur in DOCK8 immunodeficiency syndrome. People with DOCK8 immunodeficiency syndrome have a greater-than-average risk of developing cancer, particularly cancers of the blood or skin. DOCK8 immunodeficiency syndrome is also commonly called autosomal recessive hyper-IgE syndrome. However, researchers have identified several conditions that feature elevated levels of IgE and that follow an autosomal recessive pattern of inheritance. Each of these conditions has its own set of additional signs and symptoms and a different genetic cause. Some doctors consider these conditions forms of hyper-IgE syndrome, while others consider them independent disorders.","mondoId":"MONDO:0009478","node":{"canonicalSlug":"dock8-immunodeficiency","comparisons":[{"documentSha256":"b646afac03710135c6b6d266c915d3641e1237dd0c8a47008080127dda84a9a6","key":"legacy-dock8-immunodeficiency","kind":"legacy","label":"combined immunodeficiency due to DOCK8 deficiency","memberIds":["MONDO:0009478"],"mondoId":"MONDO:0009478","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/dock8-immunodeficiency.b646afac03710135c6b6d266c915d3641e1237dd0c8a47008080127dda84a9a6.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Combined immunodeficiency due to DOCK8 deficiency","originalSourceId":"ORPHA:217390","paragraphs":["DOCK8 immunodeficiency syndrome is a disorder of the immune system. The condition is characterized by recurrent infections that are severe and can be life-threatening. The infections can be caused by bacteria, viruses, or fungi. Skin infections cause rashes, blisters, accumulations of pus (abscesses), open sores, and scaling. People with DOCK8 immunodeficiency syndrome also tend to have frequent bouts of pneumonia and other respiratory tract infections. Other immune system-related problems in people with DOCK8 immunodeficiency syndrome include an inflammatory skin disorder called eczema, food or environmental allergies, and asthma. DOCK8 immunodeficiency syndrome is characterized by abnormally high levels of an immune system protein called immunoglobulin E (IgE) in the blood; the levels can be more than 10 times higher than normal for no known reason. IgE normally triggers an immune response against foreign invaders in the body, particularly parasitic worms, and plays a role in allergies. It is unclear why people with DOCK8 immunodeficiency syndrome have such high levels of this protein. People with DOCK8 immunodeficiency syndrome also have highly elevated numbers of certain white blood cells called eosinophils (hypereosinophilia). Eosinophils aid in the immune response and are involved in allergic reactions. Some people with DOCK8 immunodeficiency syndrome have neurological problems, such as paralysis that affects the face or one side of the body (hemiplegia). Blockage of blood flow in the brain or abnormal bleeding in the brain, both of which can lead to stroke, can also occur in DOCK8 immunodeficiency syndrome. People with DOCK8 immunodeficiency syndrome have a greater-than-average risk of developing cancer, particularly cancers of the blood or skin. DOCK8 immunodeficiency syndrome is also commonly called autosomal recessive hyper-IgE syndrome. However, researchers have identified several conditions that feature elevated levels of IgE and that follow an autosomal recessive pattern of inheritance. Each of these conditions has its own set of additional signs and symptoms and a different genetic cause. Some doctors consider these conditions forms of hyper-IgE syndrome, while others consider them independent disorders."],"rawAttribution":"MONDO:0009478","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:14Z","upstream":"GARD:0002816","url":"https://rarediseases.info.nih.gov/diseases/2816"},"ownColumnKeys":["population-200c4488f51e17d84e10","population-52ab1e7d846eb19ecfdd"],"publication":"published","relationships":[{"kind":"parent","label":"hyper-IgE syndrome","mondoId":"MONDO:0018037","slug":"hyper-ige"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/dock8-immunodeficiency-syndrome"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"00d4710d1d3fe210e251917d302c0a1075b04b1e1300eb32cb233a35ec19b127","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002090","is_excluded":false,"label":"Pneumonia","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0395f054842b369b0365e8a7f8596d3b757ee828fdc868a329dd4c4e81dc2d84","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000389","is_excluded":false,"label":"Chronic otitis media","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"09da94b197819f48b5786a3dc265e04d6d266c1f4afbc064f23a894e4d71c659","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"91/108","hpo_id":"HP:0500093","is_excluded":false,"label":"Food allergy","onset_id":null,"reference":"PMID:19776401;PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1634202d1f495ac9fb9f0b358d64e087bad907234e3b7870099f04ab10100bca","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"8/11","hpo_id":"HP:0011108","is_excluded":false,"label":"Recurrent sinusitis","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"20893992683e1fe0a7898a967ff45590c91e027231bb16459906271f86b0eb82","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005406","is_excluded":false,"label":"Recurrent bacterial skin infections","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"213a345a1ac39c6d7ef0b20c7438654ca2ee656a84771a17a0cdc2e613f768e0","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012203","is_excluded":false,"label":"Unusual fungal nail infection","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2696b017d1ba380e8d03781a2b6973e6fcc8313dca9b1b9824f2115380cabcfb","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"6/11","hpo_id":"HP:0003237","is_excluded":false,"label":"Increased circulating IgG concentration","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"272192a07a80cf363a3581a358f2d671604e44b40fa2b1d5c65b25a6b4a405bd","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011108","is_excluded":false,"label":"Recurrent sinusitis","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2c4f0b7039e0b30f861dbbc6fa8228bf053b9bd2eb9ad8a643df47ae0fce77fc","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"58/108","hpo_id":"HP:0002099","is_excluded":false,"label":"Asthma","onset_id":null,"reference":"PMID:19776401;PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"30b93fb8c88eb93e3f2dde80f83c689ab5d05f0e4098b07f8530b279a46ec178","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"4/134","hpo_id":"HP:0025419","is_excluded":false,"label":"Pulmonary pneumatocele","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"31dfdf8049c5037651e1f313cd97a9c3c9c5c35dcb65fd1991c4c755fafc38e9","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0200043","is_excluded":false,"label":"Verrucae","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"36821bffc8369872fac45920f2ad4723524f69c4c7efb7754e5d38e66e2041d1","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0002850","is_excluded":false,"label":"Decreased circulating IgM concentration","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3696fafd31050f41af74f6916dc90a9cf14a162033a28fbc87005edb1bb55da7","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"124/136","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"37dda3dd76fae1c333e3301d76d2bfec91dd3fc988566a76fbd845d0bf586856","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"23/79","hpo_id":"HP:0100806","is_excluded":false,"label":"Sepsis","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3c55d570cc083708cbda7d22878323c94ff8a5f164c27e6bf0d571ab658723f5","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001047","is_excluded":false,"label":"Atopic dermatitis","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"42e00840f8b6d66673be0313cea395c5f7211a7c1762928e14a147335956ee10","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0002718","is_excluded":false,"label":"Recurrent bacterial infections","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4332fcbea139fd6a06f7cf58dbd17f16160cfabee8c20004a630250ebfd6137f","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"2/11","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"56c888373c351108153d95e32623be0ac0e546d8b2b00f2d017be2d323870e1d","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"9/97","hpo_id":"HP:0410323","is_excluded":false,"label":"Drug allergy","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"585b983b20821cca03635cc8dcaf950760fd5c2992163ac0d2269a084beb8fc6","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004429","is_excluded":false,"label":"Recurrent viral infections","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"699dc8f2a13edd96c4e6e1cf984fdf5b390ad2af0a90ece9d8b8a73df6e920c7","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"10/11","hpo_id":"HP:0003212","is_excluded":false,"label":"Increased circulating IgE concentration","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"69d9236437b48941e56266dd637210a0447aa00fd2945a3e887adee2d6501bce","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"10/11","hpo_id":"HP:0000403","is_excluded":false,"label":"Recurrent otitis media","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"69da6303530c697c2e94f4f9cf05ce7a5ae64241a2514358cc98760a5cd587e1","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0001047","is_excluded":false,"label":"Atopic dermatitis","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"79808c2bd97821990b2c9d40dfffffa49e54d9155e637c75ea4dc3c32797a783","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"4/11","hpo_id":"HP:0032185","is_excluded":false,"label":"Disseminated molluscum contagiosum","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7a77ee770930598201cef257599b5a8ffe103b20ad81707faa32496d1b7f47df","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005425","is_excluded":false,"label":"Recurrent sinopulmonary infections","onset_id":null,"reference":"OMIM:243700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8cfa8eb31f536c8b0f09db395ac7fa6e37d29b7c9be0061d42694fa2745ec948","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0200042","is_excluded":false,"label":"Skin ulcer","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"903bbf9d6a98cbe9ff27bbd3607356ee36d1b7c00ccc1a897ed77a942b602614","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0032218","is_excluded":false,"label":"Decreased total CD4+ T cell proportion","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"934b4160b133d084c9ef1fa4fba1f35dad82bccf020b152affd74610cdd0c337","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"7/136","hpo_id":"HP:0030991","is_excluded":false,"label":"Sclerosing cholangitis","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9358bf55d246846b7e4038f0ff4c58b92d61bf9beda18f887f4f962f2e7f7dfc","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"95778c2d844198aaf6bb1e0327acbb0f6f188508c82d4d7d72e8d2c6ebdd79f6","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"22/97","hpo_id":"HP:0003193","is_excluded":false,"label":"Allergic rhinitis","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"970298651c7022157e3da45b8a01bc559ae32ca4bac8971a9112501360c2f171","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006763","is_excluded":false,"label":"Anal canal squamous carcinoma","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"98fe339075583b5f97da91af2c6f6f780d71269dbf64d37191200a986e234dca","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"57/135","hpo_id":"HP:0002110","is_excluded":false,"label":"Bronchiectasis","onset_id":null,"reference":"PMID:19776401;PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9d2bb86cb39ce2e8ea0bc23742063869dfdc56e8ce9f08bac513da8566677410","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"2/11","hpo_id":"HP:0410151","is_excluded":false,"label":"Eosinophilic infiltration of the esophagus","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a602497c9eaa5f494cd15a872d2a7fdc29d285014b90dbfd7160827141432e2e","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"144/146","hpo_id":"HP:0000964","is_excluded":false,"label":"Eczematoid dermatitis","onset_id":null,"reference":"PMID:19776401;PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a7a0422b2ed28595bcf10948489fed630a1e6ad5b98253a09b7a2c7c9984fba8","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"10/11","hpo_id":"HP:0001880","is_excluded":false,"label":"Increased total eosinophil count","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b48aef7f4069081fb925b7d0f7d9c500cd87b2d07250a9a482063f92605fb793","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"3/11","hpo_id":"HP:0002860","is_excluded":false,"label":"Squamous cell carcinoma","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b855b185005b09aa461e754e294b944d620a92391ba1d0dcac30fc97c4a4676c","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002860","is_excluded":false,"label":"Squamous cell carcinoma","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"bd175346e36b6f812c07ce6749197cbee534cb380c7f5170e77b6835a9f9fd66","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"67/136","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c21f783da58aeb0b727af42b1e2c5f35d2b39b0738ea699aa7ea823042598318","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005401","is_excluded":false,"label":"Recurrent Candida infection","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c2a348605b4a4fb89f3a6ae858bb9f38a0cf3f5e0d9f300fc007a5b31430a3d7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030417","is_excluded":false,"label":"Squamous cell carcinoma of the vulva","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c4c66fdbe6939fe54e66528c0f348f49e2863c9a0d3cdeb912d28edf2ff1ff6c","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"17/136","hpo_id":"HP:0002960","is_excluded":false,"label":"Autoimmunity","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c52b388dba1f0ed61c07aa470e033cb07eebdd0d205642fba3d586333363aa3a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"8/79","hpo_id":"HP:0002754","is_excluded":false,"label":"Osteomyelitis","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ca117ee9c1fd1cf8ee306010e7491e632f4edfcf12e1d385fa18ba825a483da5","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"16/97","hpo_id":"HP:0100845","is_excluded":false,"label":"Anaphylactic shock","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cb3cf3b7dde5fd52f57d4f1d96232a90b1e918b2f682b14a0e6ec2d7eabc3728","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"70/84","hpo_id":"HP:0031292","is_excluded":false,"label":"Cutaneous abscess","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"cfff3f75e3427431f084835fa29c624e9440e54aa7bb1e63d8b9fa8ac9ed2b87","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002138","is_excluded":false,"label":"Subarachnoid hemorrhage","onset_id":null,"reference":"OMIM:243700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ddfd5c42814749d45b8d1e3a29ff5b72ed69dd78cb848006377ef13b3b970ea0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005403","is_excluded":false,"label":"Decreased total T cell count","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e020ceee54deffeb732d135d2d6622720dafac4d9181ef1378edf1b83a1c6ae1","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"6/10","hpo_id":"HP:0040218","is_excluded":false,"label":"Reduced total natural killer cell count","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e770b57b0f29f8331873221ac47ccd1901ca8c8c623589c7b155925beafa9737","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0005318","is_excluded":false,"label":"Cerebral vasculitis","onset_id":null,"reference":"OMIM:243700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"f03c376119f129e1d184ddf5badd0e8b62d7a8d95877fc2c7b279dadbc2a9862","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"18/136","hpo_id":"HP:0031691","is_excluded":false,"label":"Severe viral infection","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f08c894210f20e2ea9eb371b8fc6d3d684bccb5b9bd97b9e86e2cbd6fc8a5062","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002841","is_excluded":false,"label":"Recurrent fungal infections","onset_id":null,"reference":"OMIM:243700","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f64ddcf6fcebec7a75d6eebb12da55f42800c1d16e9a56685b88b95bfca6244b","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003212","is_excluded":false,"label":"Increased circulating IgE concentration","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f671d4cfefa31ce13e09fa7536a9a6266f0a9b6e18d8b3737af99059c81db849","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"8/11","hpo_id":"HP:0006532","is_excluded":false,"label":"Recurrent pneumonia","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f68484c90465cd432f0c07db198ea58b00ef8b42eaed0554fcadafeffa7aae45","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002099","is_excluded":false,"label":"Asthma","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"f91174eb4664c2adf2a0fcc5bb78508e75229dbb684d33377baf3fb6f9d91f22","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0004429","is_excluded":false,"label":"Recurrent viral infections","onset_id":null,"reference":"PMID:19776401","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fa658b5bd3e781b61b0f18f45e2db046dabb73a8535ac1e78e87cdc17579c902","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:217390","disease_name":"Combined immunodeficiency due to DOCK8 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010976","is_excluded":false,"label":"Decreased total B cell count","onset_id":null,"reference":"ORPHA:217390","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fa6c8b36c0cd6cdfe3f4878398e42b78ad0e0b62be6b89e35ea13088f9496793","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"PCS","frequency_raw":"40/109","hpo_id":"HP:0032163","is_excluded":false,"label":"Unusual molluscum contagiosum","onset_id":null,"reference":"PMID:25627830","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"fdcb0f8f462513bd74080518d599b1bc4670b05b46d4f194776cf8bdd396f13e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:243700","disease_name":"Hyper-IgE syndrome 2, autosomal recessive, with recurrent infections","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002301","is_excluded":false,"label":"Hemiplegia","onset_id":null,"reference":"OMIM:243700","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2816\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009478\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0002816</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>DOCK8 immunodeficiency syndrome is a disorder of the immune system. The condition is characterized by recurrent infections that are severe and can be life-threatening. The infections can be caused by bacteria, viruses, or fungi. Skin infections cause rashes, blisters, accumulations of pus (abscesses), open sores, and scaling. People with DOCK8 immunodeficiency syndrome also tend to have frequent bouts of pneumonia and other respiratory tract infections. Other immune system-related problems in people with DOCK8 immunodeficiency syndrome include an inflammatory skin disorder called eczema, food or environmental allergies, and asthma. DOCK8 immunodeficiency syndrome is characterized by abnormally high levels of an immune system protein called immunoglobulin E (IgE) in the blood; the levels can be more than 10 times higher than normal for no known reason. IgE normally triggers an immune response against foreign invaders in the body, particularly parasitic worms, and plays a role in allergies. It is unclear why people with DOCK8 immunodeficiency syndrome have such high levels of this protein. People with DOCK8 immunodeficiency syndrome also have highly elevated numbers of certain white blood cells called eosinophils (hypereosinophilia). Eosinophils aid in the immune response and are involved in allergic reactions. Some people with DOCK8 immunodeficiency syndrome have neurological problems, such as paralysis that affects the face or one side of the body (hemiplegia). Blockage of blood flow in the brain or abnormal bleeding in the brain, both of which can lead to stroke, can also occur in DOCK8 immunodeficiency syndrome. People with DOCK8 immunodeficiency syndrome have a greater-than-average risk of developing cancer, particularly cancers of the blood or skin. DOCK8 immunodeficiency syndrome is also commonly called autosomal recessive hyper-IgE syndrome. However, researchers have identified several conditions that feature elevated levels of IgE and that follow an autosomal recessive pattern of inheritance. Each of these conditions has its own set of additional signs and symptoms and a different genetic cause. Some doctors consider these conditions forms of hyper-IgE syndrome, while others consider them independent disorders.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2816\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"dock8-immunodeficiency","sourceDocuments":[{"name":"GARD: Combined immunodeficiency due to DOCK8 deficiency","reviewed":null,"source_release":"2026-10-21T17:04:14Z","url":"https://rarediseases.info.nih.gov/diseases/2816"},{"name":"MONDO: combined immunodeficiency due to DOCK8 deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009478"}],"sourceNote":"","synonyms":["AR hyperimmunoglobulin E syndrome","AR-HIES","autosomal recessive hyper IgE syndrome","Cid due to DOCK8 deficiency","combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency","combined immunodeficiency due to DOCK8 deficiency","dedicator of cytokinesis 8 deficiency","DOCK8 deficiency","DOCK8 immunodeficiency syndrome","HIES autosomal recessive","hyper Ig E syndrome, autosomal recessive","hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive"],"takeawayHtml":"","title":"combined immunodeficiency due to DOCK8 deficiency"},"schemaVersion":1}
